Does SIMVASTATIN Cause Hyperphosphataemia? 111 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Hyperphosphataemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.4% of all adverse event reports for SIMVASTATIN.
111
Reports of Hyperphosphataemia with SIMVASTATIN
0.4%
of all SIMVASTATIN reports
111
Deaths
105
Hospitalizations
How Dangerous Is Hyperphosphataemia From SIMVASTATIN?
Of the 111 reports, 111 (100.0%) resulted in death, 105 (94.6%) required hospitalization, and 98 (88.3%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 111 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which SIMVASTATIN Alternatives Have Lower Hyperphosphataemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS